Zobrazeno 1 - 10
of 35
pro vyhledávání: '"Yuh-Jin Liang"'
Autor:
Yuh-Jin Liang, Cheng-Pu Sun, Yu-Chen Hsu, Yi-Wen Chen, I-An Wang, Chien-Wei Su, Mi-Hua Tao, Jaw-Ching Wu
Publikováno v:
Journal of Biomedical Science, Vol 27, Iss 1, Pp 1-17 (2020)
Abstract Background Hepatitis D virus (HDV) infection may induce fulminant hepatitis in chronic hepatitis B patients (CHB) or rapid progression of CHB to cirrhosis or hepatocellular carcinoma. There is no effective treatment for HDV infection. HDV en
Externí odkaz:
https://doaj.org/article/4858e7056bd14fbb8d5fe236ceb4409e
Autor:
Kai-Chun Cheng, Ruey-Jen Lin, Jing-Yan Cheng, Sheng-Hung Wang, Jyh-Cherng Yu, Jen-Chine Wu, Yuh-Jin Liang, Huan-Ming Hsu, John Yu, Alice L. Yu
Publikováno v:
EBioMedicine, Vol 45, Iss , Pp 25-38 (2019)
Background: The transcription factor Nrf2 is a master regulator of antioxidant response. While Nrf2 activation may counter increasing oxidative stress in aging, its activation in cancer can promote cancer progression and metastasis, and confer resist
Externí odkaz:
https://doaj.org/article/fe4a623bd21a46bc8e0acc2b1b171009
Autor:
Chih‐Li Chen, Yu‐Shuen Tsai, Yen‐Hua Huang, Yuh‐Jin Liang, Ya‐Yun Sun, Chien‐Wei Su, Gar‐Yang Chau, Yi‐Chen Yeh, Yung‐Sheng Chang, Jui‐Ting Hu, Jaw‐Ching Wu
Publikováno v:
Hepatology Communications, Vol 2, Iss 11, Pp 1392-1407 (2018)
Lymphoid enhancer factor 1 (LEF1) activity is associated with progression of several types of cancers. The role of LEF1 in progression of hepatocellular carcinoma (HCC) remains poorly known. We investigated LEF1 expression in HCC and its interactions
Externí odkaz:
https://doaj.org/article/0005d62db0a740039803f2ea121212ef
Publikováno v:
Cells, Vol 11, Iss 4, p 634 (2022)
Sorafenib is a small molecule that blocks tumor proliferation by targeting the activity of multi-kinases for the treatment of advanced hepatocellular carcinoma (HCC). Increasing sorafenib resistance following long-term treatment is frequently encount
Externí odkaz:
https://doaj.org/article/c21c6e4c0af9434ba980e10ac9c518b4
Autor:
YUH-JIN LIANG, 梁毓津
96
HPV16, a high-risk tumorigenic virus, has been identified as one of the causative agents for the development of cervical cancer. Subsequent to viral infection, the constitutive expression of the viral oncoprotein E6 and oncoprotein E7 plays a
HPV16, a high-risk tumorigenic virus, has been identified as one of the causative agents for the development of cervical cancer. Subsequent to viral infection, the constitutive expression of the viral oncoprotein E6 and oncoprotein E7 plays a
Externí odkaz:
http://ndltd.ncl.edu.tw/handle/66992673614171219185
Autor:
Yuh-Jin Liang, 梁毓津
81
Spinach chloroplast RNA polymerase from crude lysates was able to recognize bacterial histidine and threonineterminators. To determine whether chloroplast RNA polymerase would terminate other baterial terminators invitro,several terminators i
Spinach chloroplast RNA polymerase from crude lysates was able to recognize bacterial histidine and threonineterminators. To determine whether chloroplast RNA polymerase would terminate other baterial terminators invitro,several terminators i
Externí odkaz:
http://ndltd.ncl.edu.tw/handle/26127515371857115884
Publikováno v:
Journal of the Chinese Medical Association. 85:972-980
Hepatocellular carcinoma (HCC) is among the leading causes of cancer-related death worldwide. The molecular pathogenesis of HCC involves multiple signaling pathways. This study utilizes systems and bioinformatic approaches to investigate the pathogen
Autor:
YUH-JIN LIANG
Publikováno v:
Glycoconjugate Journal. 39:177-195
Expression profiles of glycosphingolipids (GSLs) in human embryonic stem cell (hESC) lines and their differentiated embryoid body (EB) outgrowth cells, consisting of three germ layers, were surveyed systematically. Several globo- and lacto-series GSL
Autor:
Wei Teng, Kung Hao Liang, Chien Wei Su, Mi-Hua Tao, Rui Dung Teng, Yen Hua Huang, Yi-Wen Chen, Chung Chih Lin, Jaw Ching Wu, Yuh-Jin Liang, Chih Li Chen, Cheng Pu Sun
Publikováno v:
Hepatology (Baltimore, Md.)References. 74(2)
Background and aims PreS mutants of HBV have been reported to be associated with HCC. We conducted a longitudinal study of the role of HBV preS mutations in the development of HCC, particularly in patients with chronic hepatitis B (CHB) having low HB
Autor:
Gar Yang Chau, Yu Shuen Tsai, Chih Li Chen, Jui Ting Hu, Ya Yun Sun, Yuh-Jin Liang, Yung Sheng Chang, Chien Wei Su, Yi Chen Yeh, Yen Hua Huang, Jaw Ching Wu
Publikováno v:
Hepatology Communications
Hepatology Communications, Vol 2, Iss 11, Pp 1392-1407 (2018)
Hepatology Communications, Vol 2, Iss 11, Pp 1392-1407 (2018)
Lymphoid enhancer factor 1 (LEF1) activity is associated with progression of several types of cancers. The role of LEF1 in progression of hepatocellular carcinoma (HCC) remains poorly known. We investigated LEF1 expression in HCC and its interactions